Key result
Endomyocardial biopsy is required to diagnose inflammatory cardiomyopathy and guide targeted therapy.
Endomyocardial biopsy with detailed histopathological, immunohistochemical, and microbiological evaluation is essential for the definitive diagnosis and targeted treatment of inflammatory cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Supports biopsy-guided diagnosis and therapy in inflammatory cardiomyopathy; leaves open randomized outcome trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kuchynka et al. (2009) conducted a review in Inflammatory cardiomyopathy. Endomyocardial biopsy-guided treatment was evaluated. Endomyocardial biopsy with detailed histopathological, immunohistochemical, and microbiological evaluation is required to establish the diagnosis of inflammatory cardiomyopathy and guide targeted therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: